The Atlantic Rift: FDA Allows Peptide CompoundingβWhere Does the UK Stand?
Analysing the recent US FDA announcement on peptide compounding for 14 substances. What does this mean for UK peptide research and MHRA regulations? The world of peptide research is moving away from regulatory ambiguity. For years, the landscape has been defined by "Research Use Only" (RUO) labels a…